Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Uncategorized

Morgan Stanley Maintains Underweight on AutoNation, Raises Price Target to $65

Morgan Stanley maintains AutoNation (NYSE:AN) with a Underweight and raises the price target from $60 to $65.

byBenzinga Newsdesk

April 22, 2021

1 minute read

Morgan Stanley maintains AutoNation (NYSE:AN) with a Underweight and raises the price target from $60 to $65.

Monday’s Market Minute: Previewing The End Of September

By TD Ameritrade Network

Today, 7:05 PM

Another busy week for traders and investors, but it only takes a market minute to get ahead of what could move markets.

BBBY

Uncategorized

Putting GameStop, AMC Mania Behind, Hedge Funds Are Looking Beyond Equities For Short Bets

By Madhukumar Warrier

Today, 7:05 PM

After recording huge losses following the GameStop Corp. (NYSE: GME) trading frenzy earlier this year, hedge funds are now looking beyond equities to focus on junk- and investment-grade rated bonds for short bets.

AMC

Craig-Hallum Initiates Coverage On Zuora with Buy Rating, Announces Price Target of $24

By Benzinga Newsdesk

Today, 7:05 PM

Craig-Hallum analyst Chad Bennett initiates coverage on Zuora (NYSE:ZUO) with a Buy rating and announces Price Target of $24.

ZUO

Sierra Oncology Bets $216M On AstraZeneca’s BET Inhibitor For Myelofibrosis

By Vandana Singh

Today, 7:05 PM

Sierra Oncology Inc (NASDAQ:SRRA) has acquired an exclusive global license from AstraZeneca Plc (NASDAQ:AZN) for AZD5153, a potent, and selective BRD4 BET inhibitor…

AZN

Morgan Stanley Maintains Underweight on AutoNation, Raises Price Target to $65

Related Posts

Monday’s Market Minute: Previewing The End Of September

Putting GameStop, AMC Mania Behind, Hedge Funds Are Looking Beyond Equities For Short Bets

Craig-Hallum Initiates Coverage On Zuora with Buy Rating, Announces Price Target of $24

Sierra Oncology Bets $216M On AstraZeneca’s BET Inhibitor For Myelofibrosis